GlassScriptPhysician profile
Amy E Blancke
NPI 1538729421
$7,499.65
in general payments reported to CMS, 2019-2025
30 companies · $1,382 in 2025
The $1,382 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $295 · 2022: $419 · 2023: $3,049 · 2024: $2,355 · 2025: $1,382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,599 · Travel and Lodging: $1,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,598.94 |
| Travel and Lodging | $1,186.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,261.82 | 2022-2024 | Micra, Crome Dr Mri Surescan |
| Amgen INC. | $556.43 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $533.89 | 2023-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $521.44 | 2023-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $486.80 | 2022-2025 | |
| Scpharmaceuticals INC. | $470.98 | 2023-2025 | |
| Pfizer INC. | $415.94 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $335.83 | 2023-2024 | Farxiga, Lokelma |
| Lexicon Pharmaceuticals, INC. | $230.63 | 2023-2024 | Inpefa |
| Genzyme Corporation | $180.68 | 2023-2025 | |
| Heartflow, INC. | $170.23 | 2023-2024 | Ffrct |
| Glaxosmithkline, LLC. | $167.06 | 2025 | Arexvy, Shingrix |
| Sanofi-Aventis U.S. LLC | $157.96 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.36 | 2021-2024 | Jardiance |
| Boston Scientific Corporation | $123.96 | 2023-2025 | Watchman Flx, Latitude Communicator Power Supply |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $117.62 | 2023-2025 | Nexletol |
| Rhythm Pharmaceuticals, INC. | $113.06 | 2021 | |
| Inspire Medical Systems, INC. | $96.03 | 2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $89.88 | 2025 | Amvuttra, Onpattro |
| Cleerly, INC. | $82.18 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Amarin Pharma, INC. | $49.51 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.77 | 2023-2024 | Lifevest |
| Vertex Pharmaceuticals Incorporated | $23.14 | 2025 | |
| Atricure, INC. | $22.79 | 2024 | |
| Novo Nordisk INC | $22.79 | 2022 | |
| Lantheus Medical Imaging, INC. | $22.14 | 2024 | |
| Janssen Pharmaceuticals, INC | $18.32 | 2024 | Xarelto |
| Edwards Lifesciences Corporation | $17.67 | 2022 | |
| G Medical Diagnostic Services, INC. | $12.91 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $8.83 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Blancke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.